Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Imatinib","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=imatinib","facts":[{"label":"Active ingredient \/ generic name","value":"imatinib"},{"label":"ATC code","value":"L01EA01"},{"label":"Administration route","value":"Oral"}]},{"title":"Lipitor 40 mg (Turkish record)","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=lipitor-40-mg","facts":[{"label":"Active ingredient \/ generic name","value":"Atorvastatin Kalsiyum"},{"label":"ATC code","value":"C10AA05"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"DailyMed GLEEVEC SPL v41; effective 2026-07-13; checked 2026-11-04; 7.3 and 12.3"}],"sources":[{"label":"GLEEVEC U.S. prescribing information (DailyMed)","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=211ef2da-2868-4a77-8055-1cb2cd78e24b"},{"label":"FDA: clinical examples of drugs interacting with CYP enzymes and transporter systems","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:35740","available":true}}